首页 > 最新文献

Obesity Facts最新文献

英文 中文
Nomogram for Predicting Suboptimal Weight Loss at Three Years after Roux-en-Y Gastric Bypass Surgery in Chinese Patients with Obesity and Type 2 Diabetes. 预测中国肥胖和2型糖尿病患者Roux-en-Y胃旁路手术后3年亚理想体重减轻的Nomogram。
IF 4.7 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-01 Epub Date: 2025-01-15 DOI: 10.1159/000542923
Yiming Si, Hongwei Zhang, Xiaodong Han, Weijie Liu, Yinfang Tu, Xiaojing Ma, Haoyong Yu, Yuqian Bao

Introduction: Strategies to address suboptimal weight loss after Roux-en-Y gastric bypass (RYGB) can be developed if at-risk patients are identified in advance. This study aimed to build a pre-surgery prediction nomogram for early prediction of insufficient weight loss (IWL) or weight regain (WR) after bariatric surgery in Chinese patients.

Methods: In this retrospective study, 187 patients with obesity and type 2 diabetes who underwent laparoscopic RYGB were followed yearly for 3 years. Suboptimal weight loss included IWL and WR. IWL was defined as a total weight loss percentage of <25% at 1 year postoperatively, and WR was defined as a maximum weight loss percentage of >20% at 3 years postoperatively. Multivariate logistic regression was performed to identify independent predictors and to establish a nomogram to predict the occurrence of suboptimal weight loss.

Results: Multivariate logistic regression revealed that male sex (OR 4.268, 95% CI: 1.413-12.890), body mass index (OR 0.816, 95% CI: 0.705-0.946), and glycated hemoglobin (OR 1.493, 95% CI: 1.049-2.126) were independent predictors of IWL/WR. The AUC value of the nomogram constructed from the above three factors was 0.781. The Hosmer-Lemeshow test showed that the model had a good fit (p = 0.143). The calibration curve of the nomogram is close to an ideal diagonal line. Furthermore, the decision curve analysis demonstrated the good net benefits of the model.

Conclusions: A nomogram based on pre-surgery factors was developed to predict postoperative IWL/WR. This provides a convenient and useful tool for predicting suboptimal weight loss before surgery.

导言:如果预先确定有风险的患者,可以制定策略来解决Roux-en-Y胃旁路手术(RYGB)后的亚理想体重减轻。本研究旨在建立一个术前预测图,用于早期预测中国患者减肥手术后体重减轻不足(IWL)或体重恢复(WR)。方法:回顾性研究187例接受腹腔镜RYGB治疗的肥胖合并2型糖尿病患者,每年随访3年。次优减重包括IWL和WR。IWL的定义是术后3年总体重下降20%。采用多变量logistic回归来确定独立的预测因子,并建立方差图来预测次优减肥的发生。结果:多因素logistic回归显示,男性(OR 4.268, 95% CI: 1.413-12.890)、体重指数(OR 0.816, 95% CI: 0.705-0.946)和糖化血红蛋白(OR 1.493, 95% CI: 1.049-2.126)是IWL/WR的独立预测因子。由上述三个因素构建的nomogram AUC值为0.781。Hosmer-Lemeshow检验表明模型拟合良好(p = 0.143)。图的标定曲线接近于理想对角线。此外,决策曲线分析表明,该模型具有良好的净效益。结论:基于术前因素的nomogram预测术后IWL/WR。这提供了一个方便和有用的工具来预测手术前的体重下降。
{"title":"Nomogram for Predicting Suboptimal Weight Loss at Three Years after Roux-en-Y Gastric Bypass Surgery in Chinese Patients with Obesity and Type 2 Diabetes.","authors":"Yiming Si, Hongwei Zhang, Xiaodong Han, Weijie Liu, Yinfang Tu, Xiaojing Ma, Haoyong Yu, Yuqian Bao","doi":"10.1159/000542923","DOIUrl":"10.1159/000542923","url":null,"abstract":"<p><strong>Introduction: </strong>Strategies to address suboptimal weight loss after Roux-en-Y gastric bypass (RYGB) can be developed if at-risk patients are identified in advance. This study aimed to build a pre-surgery prediction nomogram for early prediction of insufficient weight loss (IWL) or weight regain (WR) after bariatric surgery in Chinese patients.</p><p><strong>Methods: </strong>In this retrospective study, 187 patients with obesity and type 2 diabetes who underwent laparoscopic RYGB were followed yearly for 3 years. Suboptimal weight loss included IWL and WR. IWL was defined as a total weight loss percentage of <25% at 1 year postoperatively, and WR was defined as a maximum weight loss percentage of >20% at 3 years postoperatively. Multivariate logistic regression was performed to identify independent predictors and to establish a nomogram to predict the occurrence of suboptimal weight loss.</p><p><strong>Results: </strong>Multivariate logistic regression revealed that male sex (OR 4.268, 95% CI: 1.413-12.890), body mass index (OR 0.816, 95% CI: 0.705-0.946), and glycated hemoglobin (OR 1.493, 95% CI: 1.049-2.126) were independent predictors of IWL/WR. The AUC value of the nomogram constructed from the above three factors was 0.781. The Hosmer-Lemeshow test showed that the model had a good fit (p = 0.143). The calibration curve of the nomogram is close to an ideal diagonal line. Furthermore, the decision curve analysis demonstrated the good net benefits of the model.</p><p><strong>Conclusions: </strong>A nomogram based on pre-surgery factors was developed to predict postoperative IWL/WR. This provides a convenient and useful tool for predicting suboptimal weight loss before surgery.</p>","PeriodicalId":19414,"journal":{"name":"Obesity Facts","volume":" ","pages":"157-168"},"PeriodicalIF":4.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12017750/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143008103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Efficacy and Safety of Adjustable Intragastric Balloon for Weight Loss: A Systematic Review and Meta-Analysis. 可调节胃内球囊减肥的有效性和安全性:一项系统综述和荟萃分析。
IF 4.7 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-01 Epub Date: 2025-02-13 DOI: 10.1159/000542921
Guowu Sun, Chuqi Xia, Yinuo Wang, Guowu Sun, Wanyang Lei, Daoming Liang

Introduction: Adjustable intragastric balloon (aIGB), known as a novel minimally invasive therapy for obesity, provides a sustained alternative for weight loss. Weight loss is achieved by implanting a balloon into the patient's stomach, with the volume of the balloon being adjustable through the injection or extraction of physiological saline. Its key distinction from other intragastric balloons lies in post-implantation volume control. Currently, the efficacy and safety of aIGB have not been well described.

Methods: MEDLINE, Embase, and the Cochrane Library were searched for relevant articles. Efficacy and safety of aIGB were evaluated by total body weight loss (TWL) after treatment and severe adverse events.

Results: A total of 12 eligible studies with 4,981 patients were included. The average inserting time was 9.9 months, and the pooled mean TWL was 16.4% (95% CI: 0.153-0.175, I2 = 91.2%). The pooled prevalence of patients choosing upward balloon adjustment was 34.2% (95% CI: 0.220-0.485, I2 = 96.5), and all reported additional weight loss with a mean of 6.3 (4.8-9.3) kg. The pooled prevalence of patients choosing downward balloon adjustment was 9.2% (95% CI: 0.065-0.119, I2 = 73.9%), and the pooled prevalence of alleviating intolerance in these patients was 90.8% (95% CI: 0.817-0.974, I2 = 53.4%). The pooled prevalence of intolerance and early removal within 3 months was 5.7% (95% CI: 0.035-0.078, I2 = 79.8%), and the pooled prevalence of stomach ulcer was 1.1% (95% CI: 0.008-0.014, I2 = 5.1%). There was no obvious publication bias detected for these outcomes. Leave-one-out and subgroup analysis demonstrated the results were statistically reliable.

Conclusion: aIGB has the ability of significant and sustained weight loss and can effectively manage both intolerance and weight loss plateaus by adjusting the balloon volume during treatment.

.

简介:可调胃内球囊(aIGB)是一种新型的微创治疗肥胖的方法,为减肥提供了一种持续的选择。减肥是通过在患者胃中植入一个球囊来实现的,球囊的体积可以通过注射或抽取生理盐水来调节。它与其他胃内气球的主要区别在于植入后的体积控制。目前,对aIGB的疗效和安全性还没有很好的描述。方法:检索MEDLINE、Embase、Cochrane图书馆相关文献。以治疗后总体重减轻(TWL)和严重不良事件评价aIGB的疗效和安全性。结果:共纳入12项符合条件的研究,4981例患者。平均插入时间9.9个月,合并平均TWL为16.4% (95%CI 0.153 ~ 0.175, I2 = 91.2%)。选择向上调整球囊的患者的总患病率为34.2% (95%CI 0.220 - 0.485, I2 = 96.5),所有患者均报告额外体重减轻,平均为6.3 (4.8~9.3)kg。选择下行球囊调整的患者总患病率为9.2% (95%CI 0.065 ~ 0.119, I2 = 73.9%),缓解不耐受的患者总患病率为90.8% (95%CI 0.817 ~ 0.974, I2 = 53.4%)。3个月内不耐受和早期清除的总患病率为5.7% (95%CI 0.035 ~ 0.078, I2 = 79.8%),胃溃疡的总患病率为1.1% (95%CI 0.008 ~ 0.014, I2 = 5.1%)。这些结果未发现明显的发表偏倚。留一分析和亚组分析表明结果在统计学上是可靠的。结论:aIGB具有显著且持续的减重能力,在治疗过程中通过调节球囊容积可有效控制不耐受和减重平台期。
{"title":"The Efficacy and Safety of Adjustable Intragastric Balloon for Weight Loss: A Systematic Review and Meta-Analysis.","authors":"Guowu Sun, Chuqi Xia, Yinuo Wang, Guowu Sun, Wanyang Lei, Daoming Liang","doi":"10.1159/000542921","DOIUrl":"10.1159/000542921","url":null,"abstract":"<p><p><p>Introduction: Adjustable intragastric balloon (aIGB), known as a novel minimally invasive therapy for obesity, provides a sustained alternative for weight loss. Weight loss is achieved by implanting a balloon into the patient's stomach, with the volume of the balloon being adjustable through the injection or extraction of physiological saline. Its key distinction from other intragastric balloons lies in post-implantation volume control. Currently, the efficacy and safety of aIGB have not been well described.</p><p><strong>Methods: </strong>MEDLINE, Embase, and the Cochrane Library were searched for relevant articles. Efficacy and safety of aIGB were evaluated by total body weight loss (TWL) after treatment and severe adverse events.</p><p><strong>Results: </strong>A total of 12 eligible studies with 4,981 patients were included. The average inserting time was 9.9 months, and the pooled mean TWL was 16.4% (95% CI: 0.153-0.175, I2 = 91.2%). The pooled prevalence of patients choosing upward balloon adjustment was 34.2% (95% CI: 0.220-0.485, I2 = 96.5), and all reported additional weight loss with a mean of 6.3 (4.8-9.3) kg. The pooled prevalence of patients choosing downward balloon adjustment was 9.2% (95% CI: 0.065-0.119, I2 = 73.9%), and the pooled prevalence of alleviating intolerance in these patients was 90.8% (95% CI: 0.817-0.974, I2 = 53.4%). The pooled prevalence of intolerance and early removal within 3 months was 5.7% (95% CI: 0.035-0.078, I2 = 79.8%), and the pooled prevalence of stomach ulcer was 1.1% (95% CI: 0.008-0.014, I2 = 5.1%). There was no obvious publication bias detected for these outcomes. Leave-one-out and subgroup analysis demonstrated the results were statistically reliable.</p><p><strong>Conclusion: </strong>aIGB has the ability of significant and sustained weight loss and can effectively manage both intolerance and weight loss plateaus by adjusting the balloon volume during treatment. </p>.</p>","PeriodicalId":19414,"journal":{"name":"Obesity Facts","volume":" ","pages":"415-428"},"PeriodicalIF":4.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12511618/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143414871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obesity and Clinical Characteristics of Inflammatory Bowel Disease. 肥胖与炎症性肠病的临床特征
IF 4.7 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-01 Epub Date: 2025-03-28 DOI: 10.1159/000545436
Livia Biancone, Roberto Mancone, Livia Biancone, Sara Concetta Schiavone, Mariasofia Fiorillo, Chiara Menna, Stefano Migliozzi, Benedetto Neri

Introduction: The frequency of obesity and possible correlations with characteristics and outcome of inflammatory bowel disease (IBD) are undefined. Primary aim was to assess the body mass index (BMI) distribution in IBD patients in follow-up. Secondary aim was to compare clinical characteristics and course of IBD in normal weight versus overweight or obese patients.

Methods: Adult IBD patients in regular follow-up were prospectively enrolled and BMI was recorded during outpatient visits. Comparisons were assessed by the Student t-test, Mann-Whitney U test and Chi-square test, as appropriate.

Results: In the 300 IBD patients enrolled (150 Crohn's disease [CD], 150 ulcerative colitis [UC]), BMI distribution included: 16 (5.3%) underweight, 170 (56.7%) normal weight, 92 (30.7%) overweight, 22 (7.3%) obese patients. For the secondary aim, the 16 underweight patients were excluded, thus leaving 284 patients for the analysis (141 [49.6%] CD; 143 [50.4%] UC). Among these, 114 (40.2%) were overweight/obese and 170 (59.8%) normal weight. CD group included 89 (63.1%) normal weight and 52 (36.9%) overweight/obese patients. Perianal disease and refractoriness to biologics were more frequent in overweight/obese than normal weight CD patients (9 [10.1%] vs. 12 [23%], p = 0.03; 0 [0%] vs. 4 [23.4%], p = 0.01). In UC group, there were 81 (56.6%) normal weight and 62 (63.4%) overweight or obese patients.

Conclusion: In IBD patients in follow-up, the proportion of underweight patients is low. Overweight and obese CD patients showed a higher frequency of perianal disease and refractoriness to biologics. BMI may influence phenotype and responsiveness to biologics in CD.

.

背景:肥胖的频率及其与炎症性肠病(IBD)的特征和结局的可能相关性尚不明确。主要目的是在随访中评估IBD患者的身体质量指数(BMI)分布。次要目的是比较正常体重与超重或肥胖患者IBD的临床特征和病程。方法:前瞻性纳入定期随访的成年IBD患者,并在门诊就诊时记录BMI。比较采用学生t检验、Mann-Whitney u检验和卡方检验。结果:入选的300例IBD患者(150例克罗恩病,CD, 150例溃疡性结肠炎,UC), BMI分布包括:体重不足16例(5.3%),正常体重170例(56.7%),超重92例(30.7%),肥胖22例(7.3%)。对于次要目的,16例体重过轻的患者被排除在外,从而留下284例患者进行分析(141例[49.6%]CD;143 [50.4%] uc)。其中超重/肥胖114人(40.2%),体重正常170人(59.8%)。CD组89例(63.1%)体重正常,52例(36.9%)超重/肥胖。超重/肥胖患者的肛周疾病和对生物制剂的难治性比正常体重的CD患者更常见(9 [10.1%]vs 12 [23%], p=0.03;0 [0%] vs 4 [23.4%], p=0.01)。UC组体重正常81例(56.6%),超重或肥胖62例(63.4%)。结论:在IBD患者随访中,体重过轻患者比例较低。超重和肥胖的乳糜泻患者出现肛周疾病的频率更高,对生物制剂的耐受性也更高。BMI可能影响CD患者的表型和对生物制剂的反应。
{"title":"Obesity and Clinical Characteristics of Inflammatory Bowel Disease.","authors":"Livia Biancone, Roberto Mancone, Livia Biancone, Sara Concetta Schiavone, Mariasofia Fiorillo, Chiara Menna, Stefano Migliozzi, Benedetto Neri","doi":"10.1159/000545436","DOIUrl":"10.1159/000545436","url":null,"abstract":"<p><p><p>Introduction: The frequency of obesity and possible correlations with characteristics and outcome of inflammatory bowel disease (IBD) are undefined. Primary aim was to assess the body mass index (BMI) distribution in IBD patients in follow-up. Secondary aim was to compare clinical characteristics and course of IBD in normal weight versus overweight or obese patients.</p><p><strong>Methods: </strong>Adult IBD patients in regular follow-up were prospectively enrolled and BMI was recorded during outpatient visits. Comparisons were assessed by the Student t-test, Mann-Whitney U test and Chi-square test, as appropriate.</p><p><strong>Results: </strong>In the 300 IBD patients enrolled (150 Crohn's disease [CD], 150 ulcerative colitis [UC]), BMI distribution included: 16 (5.3%) underweight, 170 (56.7%) normal weight, 92 (30.7%) overweight, 22 (7.3%) obese patients. For the secondary aim, the 16 underweight patients were excluded, thus leaving 284 patients for the analysis (141 [49.6%] CD; 143 [50.4%] UC). Among these, 114 (40.2%) were overweight/obese and 170 (59.8%) normal weight. CD group included 89 (63.1%) normal weight and 52 (36.9%) overweight/obese patients. Perianal disease and refractoriness to biologics were more frequent in overweight/obese than normal weight CD patients (9 [10.1%] vs. 12 [23%], p = 0.03; 0 [0%] vs. 4 [23.4%], p = 0.01). In UC group, there were 81 (56.6%) normal weight and 62 (63.4%) overweight or obese patients.</p><p><strong>Conclusion: </strong>In IBD patients in follow-up, the proportion of underweight patients is low. Overweight and obese CD patients showed a higher frequency of perianal disease and refractoriness to biologics. BMI may influence phenotype and responsiveness to biologics in CD. </p>.</p>","PeriodicalId":19414,"journal":{"name":"Obesity Facts","volume":" ","pages":"429-444"},"PeriodicalIF":4.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12092008/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143753649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of the COVID-19 Pandemic on Psychosocial Distress in Adolescents with Obesity Compared to Those with Type 1 Diabetes: Results from the KICK-COVID Study in Germany. 与1型糖尿病患者相比,COVID-19大流行对肥胖青少年心理社会困扰的影响:来自德国KICK-COVID研究的结果
IF 4.7 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-01 Epub Date: 2025-02-17 DOI: 10.1159/000542756
Susann Weihrauch-Blüher, Susanna Wiegand, Sascha Tittel, Susanne Greber-Platzer, Stefanie Lanzinger, Clemens Kamrath, Kirsten Minden, Claudia Sengler, Sabine Linke, Antje Büssenschütt, Felix Reschke, Julia Göldel, Petra Warschburger, Reinhard W Holl

Introduction: The aim of this study was to investigate the impact of the COVID-19 pandemic on psychosocial well-being in adolescents with obesity compared to those with type 1 diabetes.

Methods: As part of the German KICK-COVID Study, adolescents aged 12-21 with overweight or obesity from the German/Austrian Adiposity Follow-up Registry (APV) completed well-being, anxiety, and depression questionnaires (WHO-5, GAD-7, PHQ-9) during routine visits amidst the COVID-19 pandemic. By multivariable linear regression models, adjusted for age, gender, and immigration background, the association between psychosocial distress, anthropometrics, and cardiometabolic risk factors was analyzed. Data were compared to those of youth with type 1 diabetes from the German/Austrian Diabetes Follow-up Registry (DPV) and normative values from the general population. Additionally, a mediation analysis examined the impact of loneliness on mental health through media consumption.

Results: From June 2021 to September 2023, 235 adolescents from 6 German and 1 Austrian pediatric obesity centers were enrolled. Results were compared to 235 age- and gender-matched participants from the DPV registry (54.04% males; mean age 15.21 ± 1.66 years) and normative values. Youth with type 1 diabetes were more anxious about their health risk, but distress factors were more pronounced in the APV group (p < 0.001). Girls from the APV group showed higher mental distress than boys across all applied questionnaires, but not for age, BMI-SDS, and migration background as predictors. Perception of loneliness correlated with poorer mental health outcomes, but it was not associated to media consumption. Comparisons with normative values revealed significantly higher depression and anxiety scores (p < 0.001) and lower well-being scores in the APV group (p < 0.01).

Conclusions: Youth with obesity and diabetes experienced significant psychosocial distress during the COVID-19 pandemic. Disease-specific differences were observed on the level of single items: Adolescents with type 1 diabetes expressed heightened concern about their health risks, while those with obesity reported lower self-esteem, increased suicidal thoughts, and fluctuating appetite. Female gender appeared to pose an additional risk factor. Media consumption was notably higher in the APV cohort. Healthcare providers should be vigilant regarding psychological comorbidities in youth with chronic conditions, particularly during periods of heightened stress.

前言:本研究的目的是研究与1型糖尿病青少年相比,COVID-19大流行对肥胖青少年心理社会健康的影响。方法:作为德国踢打- covid研究的一部分,来自德国/奥地利肥胖-随访登记处(APV)的12-21岁超重或肥胖青少年完成了幸福感、焦虑和抑郁问卷(WHO-5;GAD-7;PHQ-9)在COVID-19大流行期间的常规访问中。通过调整年龄、性别和移民背景的多变量线性回归模型,分析了心理社会困扰、人体测量学和心脏代谢危险因素之间的关系。将数据与来自德国/奥地利糖尿病随访登记处(DPV)的1型糖尿病青年患者的数据和来自一般人群的规范值进行比较。此外,一项中介分析通过媒体消费考察了孤独感对心理健康的影响。结果:从2021年6月到2023年9月,来自6个德国和1个奥地利儿科肥胖中心的235名青少年被纳入研究。结果比较了来自DPV登记处的235名年龄和性别匹配的参与者(54.04%男性;平均年龄(15.21±1.66岁)与正常值比较。1型糖尿病青年对健康风险的焦虑程度更高,但APV组的困扰因素更为明显(结论:肥胖和糖尿病青年在COVID-19大流行期间经历了显著的社会心理困扰。在单个项目的水平上观察到特定疾病的差异:患有1型糖尿病的青少年对他们的健康风险表现出高度的关注,而肥胖的青少年则表现出较低的自尊,增加的自杀念头和波动的食欲。女性似乎是另一个风险因素。媒体消费在APV群体中明显更高。医疗保健提供者应警惕青少年慢性疾病的心理合并症,特别是在压力加剧的时期。
{"title":"Impact of the COVID-19 Pandemic on Psychosocial Distress in Adolescents with Obesity Compared to Those with Type 1 Diabetes: Results from the KICK-COVID Study in Germany.","authors":"Susann Weihrauch-Blüher, Susanna Wiegand, Sascha Tittel, Susanne Greber-Platzer, Stefanie Lanzinger, Clemens Kamrath, Kirsten Minden, Claudia Sengler, Sabine Linke, Antje Büssenschütt, Felix Reschke, Julia Göldel, Petra Warschburger, Reinhard W Holl","doi":"10.1159/000542756","DOIUrl":"10.1159/000542756","url":null,"abstract":"<p><strong>Introduction: </strong>The aim of this study was to investigate the impact of the COVID-19 pandemic on psychosocial well-being in adolescents with obesity compared to those with type 1 diabetes.</p><p><strong>Methods: </strong>As part of the German KICK-COVID Study, adolescents aged 12-21 with overweight or obesity from the German/Austrian Adiposity Follow-up Registry (APV) completed well-being, anxiety, and depression questionnaires (WHO-5, GAD-7, PHQ-9) during routine visits amidst the COVID-19 pandemic. By multivariable linear regression models, adjusted for age, gender, and immigration background, the association between psychosocial distress, anthropometrics, and cardiometabolic risk factors was analyzed. Data were compared to those of youth with type 1 diabetes from the German/Austrian Diabetes Follow-up Registry (DPV) and normative values from the general population. Additionally, a mediation analysis examined the impact of loneliness on mental health through media consumption.</p><p><strong>Results: </strong>From June 2021 to September 2023, 235 adolescents from 6 German and 1 Austrian pediatric obesity centers were enrolled. Results were compared to 235 age- and gender-matched participants from the DPV registry (54.04% males; mean age 15.21 ± 1.66 years) and normative values. Youth with type 1 diabetes were more anxious about their health risk, but distress factors were more pronounced in the APV group (p < 0.001). Girls from the APV group showed higher mental distress than boys across all applied questionnaires, but not for age, BMI-SDS, and migration background as predictors. Perception of loneliness correlated with poorer mental health outcomes, but it was not associated to media consumption. Comparisons with normative values revealed significantly higher depression and anxiety scores (p < 0.001) and lower well-being scores in the APV group (p < 0.01).</p><p><strong>Conclusions: </strong>Youth with obesity and diabetes experienced significant psychosocial distress during the COVID-19 pandemic. Disease-specific differences were observed on the level of single items: Adolescents with type 1 diabetes expressed heightened concern about their health risks, while those with obesity reported lower self-esteem, increased suicidal thoughts, and fluctuating appetite. Female gender appeared to pose an additional risk factor. Media consumption was notably higher in the APV cohort. Healthcare providers should be vigilant regarding psychological comorbidities in youth with chronic conditions, particularly during periods of heightened stress.</p>","PeriodicalId":19414,"journal":{"name":"Obesity Facts","volume":" ","pages":"305-318"},"PeriodicalIF":4.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12101817/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143441620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postprandial Symptoms in a Mixed-Meal-Test after Bariatric Surgery: Clinical Experience and a Critical Review of Dumping Syndrome Definition and Management. 减肥手术后混合餐测试中的餐后症状--临床经验以及对倾倒综合征定义和管理的批判性回顾。
IF 3.9 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-01 Epub Date: 2024-10-15 DOI: 10.1159/000541780
Azat Samigullin, Julia Weihrauch, Mirko Otto, Andrea Rech, Sandra Buchenberger, Michael Morcos, Per M Humpert

Introduction: Despite recent attempts to reach a consensus on the diagnostic criteria and treatment of dumping syndrome (DS) after bariatric surgery, many questions about the clinical applicability and significance of standardized provocation tests remain unanswered. The objective of this study was to retrospectively evaluate a mixed-meal-test (MMT) based on general nutritional recommendations after bariatric surgery and its clinical value in diagnosing DS.

Methods: The MMT contained 15.5 g of protein, 10 g of fat, 20.7 g of carbohydrates, and 3.1 g of dietary fiber, totaling 241 kcal. Symptoms based on the Sigstad Score, along with blood sugar, hematocrit, pulse rate, and blood pressure, were collected as primary readouts. The analysis included 58 MMTs from 56 patients who reported postprandial symptoms indicative of DS and were referred to the clinic by surgeons or general practitioners.

Results: Although all individuals reported significant symptoms at home, the MMT showed a positive symptom score (Sigstad Score ≥7) in only 16 cases (28%). Neither a heart rate increase >10 BPM nor the 3% hematocrit increase suggested as cut-offs for early DS by the consensus paper were associated with the Sigstad Score or individually reported symptoms. None of the participants had a postprandial glucose decrease below 50 mg/dL; one fell below 60 mg/dL and 14 fell below 70 mg/dL. A blood glucose decrease below 70 mg/dL was not associated with symptoms.

Conclusion: The MMT showed that only a minority of patients reported classical DS symptoms under controlled conditions. Changes in hematocrit, heart rate, and blood sugar decrease below 70 mg/dL did not help to predict symptoms in the individuals studied. The data, in the context of existing evidence, suggest that provocation tests have little value in clinical practice and that DS as a clinical entity after bariatric surgery should be reevaluated.

导言:尽管最近人们试图就减肥手术后倾倒综合征(Dumping Syndrome,DS)的诊断标准和治疗方法达成共识,但关于标准化激惹试验的临床适用性和意义的许多问题仍未得到解答。本研究的目的是对基于减肥手术后一般营养建议的混合餐试验(MMT)及其在诊断 Dumping 综合征方面的临床价值进行回顾性评估。方法 MMT 含有 15.5 克蛋白质、10 克脂肪、20.7 克碳水化合物和 3.1 克膳食纤维,总热量为 241 千卡。主要读数包括基于 Sigstad 评分的症状、血糖、血细胞比容、脉搏和血压。分析包括 56 名患者的 58 份 MMT,这些患者报告的餐后症状提示 DS,并由外科医生或全科医生转介到诊所。结果 虽然所有患者在家中都报告了明显的症状,但只有 16 例(28%)患者的 MMT 显示出阳性症状评分(Sigstad 评分≥7)。共识文件建议的早期 DS 临界值--心率增加 10 BPM 或血细胞比容增加 3% 都与 Sigstad 评分或个人报告的症状无关。没有一位参与者的血糖降至 50 mg/dl 以下;1 人降至 60 mg/dl 以下,14 人降至 70 mg/dl 以下。血糖降至 70 毫克/分升以下与症状无关。结论 MMT 显示,在受控条件下,只有少数患者报告了典型的 DS 症状。血细胞比容、心率和血糖下降到 70 毫克/分升以下的变化无助于预测研究对象的症状。从现有证据来看,这些数据表明激惹试验在临床实践中价值不大,因此应重新评估减肥手术后 DS 这一临床实体。
{"title":"Postprandial Symptoms in a Mixed-Meal-Test after Bariatric Surgery: Clinical Experience and a Critical Review of Dumping Syndrome Definition and Management.","authors":"Azat Samigullin, Julia Weihrauch, Mirko Otto, Andrea Rech, Sandra Buchenberger, Michael Morcos, Per M Humpert","doi":"10.1159/000541780","DOIUrl":"10.1159/000541780","url":null,"abstract":"<p><strong>Introduction: </strong>Despite recent attempts to reach a consensus on the diagnostic criteria and treatment of dumping syndrome (DS) after bariatric surgery, many questions about the clinical applicability and significance of standardized provocation tests remain unanswered. The objective of this study was to retrospectively evaluate a mixed-meal-test (MMT) based on general nutritional recommendations after bariatric surgery and its clinical value in diagnosing DS.</p><p><strong>Methods: </strong>The MMT contained 15.5 g of protein, 10 g of fat, 20.7 g of carbohydrates, and 3.1 g of dietary fiber, totaling 241 kcal. Symptoms based on the Sigstad Score, along with blood sugar, hematocrit, pulse rate, and blood pressure, were collected as primary readouts. The analysis included 58 MMTs from 56 patients who reported postprandial symptoms indicative of DS and were referred to the clinic by surgeons or general practitioners.</p><p><strong>Results: </strong>Although all individuals reported significant symptoms at home, the MMT showed a positive symptom score (Sigstad Score ≥7) in only 16 cases (28%). Neither a heart rate increase >10 BPM nor the 3% hematocrit increase suggested as cut-offs for early DS by the consensus paper were associated with the Sigstad Score or individually reported symptoms. None of the participants had a postprandial glucose decrease below 50 mg/dL; one fell below 60 mg/dL and 14 fell below 70 mg/dL. A blood glucose decrease below 70 mg/dL was not associated with symptoms.</p><p><strong>Conclusion: </strong>The MMT showed that only a minority of patients reported classical DS symptoms under controlled conditions. Changes in hematocrit, heart rate, and blood sugar decrease below 70 mg/dL did not help to predict symptoms in the individuals studied. The data, in the context of existing evidence, suggest that provocation tests have little value in clinical practice and that DS as a clinical entity after bariatric surgery should be reevaluated.</p>","PeriodicalId":19414,"journal":{"name":"Obesity Facts","volume":" ","pages":"31-38"},"PeriodicalIF":3.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12017760/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Characteristics of Sarcopenia in Nonalcoholic Fatty Liver Disease: A Systemic Scoping Review. 非酒精性脂肪肝患者 "肌少症 "的临床特征:系统性范围界定综述
IF 3.9 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-01 Epub Date: 2024-10-16 DOI: 10.1159/000541650
Tingdan Ye, Ke Mi, Lin Zhu, Jonathan Li, Calvin Q Pan

Introduction: This systematic scoping review aimed to synthesize existing research findings on the clinical manifestations in patients with nonalcoholic fatty liver disease (NAFLD) and sarcopenia.

Methods: Adhering to scoping review guidelines, we comprehensively searched five databases for literature on sarcopenia's clinical manifestations in NAFLD patients from December 2013 to December 2023, meticulously compiling and synthesizing the findings.

Results: A total of 312 articles were identified, with 9 studies included in the final review. Of these, 90% were cross-sectional investigations, with 70% from Asian cohorts. Comparative analysis between patients solely afflicted with NAFLD and those additionally experiencing sarcopenia revealed discernible trends. Individuals with both conditions tended to be older, have a higher body mass index, and show a higher prevalence among females, underscoring the influence of unhealthy lifestyles and obesity. Furthermore, comorbidities like metabolic syndrome, hypertension, and diabetes have been implicated in sarcopenia manifestation among NAFLD patients. Nonetheless, the lack of standardized diagnostic criteria and patterns poses an ongoing clinical challenge for this subgroup.

Conclusions: Our review highlights distinct clinical characteristics evident in NAFLD patients with sarcopenia. However, comprehensive investigations remain scarce, impeding accurate early detection and intervention. Future research should prioritize bridging these gaps and fostering enhanced clinical management strategies.

背景:本系统性范围界定综述旨在综合非酒精性脂肪肝(NAFLD)和肌肉疏松症患者临床表现的研究结果,重点关注2013年12月至2023年12月期间发表的研究。摘要:我们对五个数据库进行了全面的系统性范围界定综述,确定了312篇文章,最终综述纳入了9项研究。大部分为横断面调查,70%来自亚洲队列。对比分析显示,患有非酒精性脂肪肝和肌肉疏松症的患者往往年龄较大,体重指数较高,女性发病率较高。这些发现强调了不健康的生活方式和肥胖的作用。常见的合并症包括代谢综合征、高血压和糖尿病。然而,标准化诊断标准的缺乏对准确识别这一患者亚群构成了重大挑战:本综述强调了患有肌肉疏松症的非酒精性脂肪肝患者的独特临床特征,如年龄较大、体重指数较高以及女性发病率较高。合并症也在其中发挥了重要作用。然而,缺乏全面的研究限制了早期检测和干预。未来的研究应针对这一患者群体制定标准化的诊断标准和有效的管理策略,以弥补这些不足。
{"title":"Clinical Characteristics of Sarcopenia in Nonalcoholic Fatty Liver Disease: A Systemic Scoping Review.","authors":"Tingdan Ye, Ke Mi, Lin Zhu, Jonathan Li, Calvin Q Pan","doi":"10.1159/000541650","DOIUrl":"10.1159/000541650","url":null,"abstract":"<p><strong>Introduction: </strong>This systematic scoping review aimed to synthesize existing research findings on the clinical manifestations in patients with nonalcoholic fatty liver disease (NAFLD) and sarcopenia.</p><p><strong>Methods: </strong>Adhering to scoping review guidelines, we comprehensively searched five databases for literature on sarcopenia's clinical manifestations in NAFLD patients from December 2013 to December 2023, meticulously compiling and synthesizing the findings.</p><p><strong>Results: </strong>A total of 312 articles were identified, with 9 studies included in the final review. Of these, 90% were cross-sectional investigations, with 70% from Asian cohorts. Comparative analysis between patients solely afflicted with NAFLD and those additionally experiencing sarcopenia revealed discernible trends. Individuals with both conditions tended to be older, have a higher body mass index, and show a higher prevalence among females, underscoring the influence of unhealthy lifestyles and obesity. Furthermore, comorbidities like metabolic syndrome, hypertension, and diabetes have been implicated in sarcopenia manifestation among NAFLD patients. Nonetheless, the lack of standardized diagnostic criteria and patterns poses an ongoing clinical challenge for this subgroup.</p><p><strong>Conclusions: </strong>Our review highlights distinct clinical characteristics evident in NAFLD patients with sarcopenia. However, comprehensive investigations remain scarce, impeding accurate early detection and intervention. Future research should prioritize bridging these gaps and fostering enhanced clinical management strategies.</p>","PeriodicalId":19414,"journal":{"name":"Obesity Facts","volume":" ","pages":"72-85"},"PeriodicalIF":3.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12017758/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Abdominal Volume Index with Asymptomatic Intracranial Arterial Stenosis in Rural Chinese Adults: A Population-Based Study. 中国农村成人腹容积指数与无症状颅内动脉狭窄的相关性:一项基于人群的研究。
IF 3.9 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-01 Epub Date: 2025-02-04 DOI: 10.1159/000543790
Qiuting Wang, Xinhao Yang, Zhengyu Yang, Xinyan Hu, Jiehong Yuan, Maoyu Li, Xiaotong Ma, Xiang Wang, Chengxuan Qiu, Qinjian Sun

Introduction: The abdominal volume index (AVI), a novel anthropometric index that reflects abdominal obesity, has been related to atherosclerosis. We sought to investigate the association of AVI with the severity and burden of asymptomatic intracranial arterial stenosis (aICAS) in a rural Chinese population.

Methods: The population-based cross-sectional study included 1,994 participants who were aged ≥40 years and living in Kongcun Town, Pingyin County, Shandong, and who had no history of clinical stroke or transient ischemic attack. We detected aICAS by combining transcranial Doppler ultrasound with magnetic resonance angiography. We used multiple logistic regression models to investigate the association between AVI and aICAS.

Results: Of the 1,994 participants, 146 were diagnosed with aICAS, including 51 with mild aICAS and 95 with moderate-to-severe aICAS. Controlling for confounding factors, a greater AVI was significantly associated with an adjusted odds ratio (OR) (95% confidence interval [CI]) of 1.08 (1.02-1.14) for having aICAS, 1.11 (1.04-1.18) for moderate-to-severe aICAS, and 1.12 (1.01-1.23) for multiple moderate-to-severe aICAS. We detected a statistical interaction of AVI with hypertension on aICAS (p for interaction = 0.011). Stratified analysis by hypertension showed a significantly independent association between AVI and aICAS in participants with hypertension (upper versus lower tertile of AVI: OR = 2.90; 95% CI: 1.65-5.10, p < 0.001) but not in those without hypertension.

Conclusion: A greater AVI is independently associated with aICAS, especially among individuals with hypertension. Moreover, AVI may help to identify both the severity and burden of aICAS.

腹容积指数(AVI)是一种反映腹部肥胖的新型人体测量指标,已被证实与动脉粥样硬化有关。我们试图在中国农村人群中调查AVI与无症状颅内动脉狭窄(aICAS)的严重程度和负担的关系。方法:以人群为基础的横断面研究纳入1994名年龄≥40岁、居住在山东省平阴县孔村镇、无临床脑卒中或短暂性脑缺血发作史的参与者。我们采用经颅多普勒超声联合磁共振血管造影检测aICAS。我们使用多元逻辑回归模型来研究AVI与aICAS之间的关系。结果:在1994名参与者中,146名被诊断为aICAS,其中51名为轻度aICAS, 95名为中重度aICAS。在控制混杂因素的情况下,患有aICAS的AVI越大,校正比值比(OR)[95%可信区间(CI)]为1.08(1.02-1.14),中度至重度aICAS为1.11(1.04-1.18),多重中至重度aICAS为1.12(1.01-1.23)。我们在aICAS上检测到AVI与高血压存在统计学上的相互作用(相互作用P =0.011)。高血压分层分析显示,高血压患者的AVI和aICAS之间存在显著的独立关联(AVI的上、下四分位数:OR=2.90;95% CI: 1.65-5.10, p结论:较大的AVI与aICAS独立相关,尤其是高血压患者。此外,AVI可能有助于确定aICAS的严重程度和负担。
{"title":"Association of Abdominal Volume Index with Asymptomatic Intracranial Arterial Stenosis in Rural Chinese Adults: A Population-Based Study.","authors":"Qiuting Wang, Xinhao Yang, Zhengyu Yang, Xinyan Hu, Jiehong Yuan, Maoyu Li, Xiaotong Ma, Xiang Wang, Chengxuan Qiu, Qinjian Sun","doi":"10.1159/000543790","DOIUrl":"10.1159/000543790","url":null,"abstract":"<p><strong>Introduction: </strong>The abdominal volume index (AVI), a novel anthropometric index that reflects abdominal obesity, has been related to atherosclerosis. We sought to investigate the association of AVI with the severity and burden of asymptomatic intracranial arterial stenosis (aICAS) in a rural Chinese population.</p><p><strong>Methods: </strong>The population-based cross-sectional study included 1,994 participants who were aged ≥40 years and living in Kongcun Town, Pingyin County, Shandong, and who had no history of clinical stroke or transient ischemic attack. We detected aICAS by combining transcranial Doppler ultrasound with magnetic resonance angiography. We used multiple logistic regression models to investigate the association between AVI and aICAS.</p><p><strong>Results: </strong>Of the 1,994 participants, 146 were diagnosed with aICAS, including 51 with mild aICAS and 95 with moderate-to-severe aICAS. Controlling for confounding factors, a greater AVI was significantly associated with an adjusted odds ratio (OR) (95% confidence interval [CI]) of 1.08 (1.02-1.14) for having aICAS, 1.11 (1.04-1.18) for moderate-to-severe aICAS, and 1.12 (1.01-1.23) for multiple moderate-to-severe aICAS. We detected a statistical interaction of AVI with hypertension on aICAS (p for interaction = 0.011). Stratified analysis by hypertension showed a significantly independent association between AVI and aICAS in participants with hypertension (upper versus lower tertile of AVI: OR = 2.90; 95% CI: 1.65-5.10, p < 0.001) but not in those without hypertension.</p><p><strong>Conclusion: </strong>A greater AVI is independently associated with aICAS, especially among individuals with hypertension. Moreover, AVI may help to identify both the severity and burden of aICAS.</p>","PeriodicalId":19414,"journal":{"name":"Obesity Facts","volume":" ","pages":"260-268"},"PeriodicalIF":3.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12101816/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143190001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
32nd European Congress on Obesity (ECO 2025) - LATE BREAKING ABSTRACTS. 第32届欧洲肥胖大会(ECO 2025) -最新摘要。
IF 3.9 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-01 Epub Date: 2025-05-28 DOI: 10.1159/000545968

n/a.

N/A。
{"title":"32nd European Congress on Obesity (ECO 2025) - LATE BREAKING ABSTRACTS.","authors":"","doi":"10.1159/000545968","DOIUrl":"10.1159/000545968","url":null,"abstract":"<p><p>n/a.</p>","PeriodicalId":19414,"journal":{"name":"Obesity Facts","volume":" ","pages":"657-829"},"PeriodicalIF":3.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144174263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electroacupuncture Combined with Press Needles Alleviates Simple Obesity via VEGF-C/VEGFR-3/PI3K/AKT Signaling Pathway. 电针联合压针通过VEGF-C/VEGFR-3/PI3K/AKT信号通路缓解单纯性肥胖
IF 4.7 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-01 Epub Date: 2025-03-19 DOI: 10.1159/000545330
Bin Xu, Minghui Xia, Zhi Yu, Yuhang Wang, Donghua Liu, Yan Wang, Shuang Wu, Bin Xu

Introduction: Simple obesity is an increasingly prevalent chronic condition. While electroacupuncture (EA) has demonstrated potential in addressing this issue, its effectiveness may be hindered by insufficient continuous stimulation and challenges related to patient adherence. This study aimed to compare the efficacy of EA alone versus EA combined with press needles in the treatment of simple obesity and to explore the underlying mechanisms contributing to weight loss.

Methods: Eighty simple obese patients with a body mass index (BMI) ≥25.0 kg/m2 were divided into two groups: the observation group (treated with EA combined with press needles) and the control group (treated with EA alone). The efficacy of the treatments was evaluated by monitoring obesity indicators. Additionally, obesity rat models were established through a high-fat diet (HFD), and rats were randomly assigned to three groups: obesity control group (no treatment), EA group, and EA combined with press needles group. Treatment outcomes were assessed by monitoring obesity indicators, examining adipose and liver cell morphology using staining techniques, and evaluating intestinal lymphatic vessel function through qRT-PCR, Western blot, and immunofluorescence analyses.

Results: The patients in the observation group exhibited significantly lower body weight (BW), BMI, body fat percentage (F%), abdominal circumference (A), waist circumference (WC), as well as serum levels of intestinal lymphatic function-related factors such as VEGF-C, delta-like ligand 4 (DLL4), and adrenomedullin (ADM) compared to the control group. Similarly, compared to EA group, EA combined with press needles significantly decreased obesity indexes, serum intestinal lymphatic function-related factors, and improved lymphatic vessel function in obese rats. Mechanistically, the VEGF-C/VEGFR-3/PI3K/AKT signaling pathway was inhibited by EA combined with press needles intervention.

Conclusion: The combined therapy of EA with press needles had shown significantly superior efficacy in treating simple obesity compared to EA treatment alone. It achieved this by modulating the VEGF-C/VEGFR-3/PI3K/AKT signaling pathway, improving lymphatic vessel structure and function, and ultimately inhibiting obesity.

.

单纯性肥胖是一种日益普遍的慢性疾病。虽然电针(EA)已经证明了解决这一问题的潜力,但其有效性可能会受到持续刺激不足和患者依从性相关挑战的阻碍。本研究旨在比较EA单独与EA联合按压针治疗单纯性肥胖的疗效,并探讨其促进体重减轻的潜在机制。方法:80例体重指数(BMI)≥25.0 kg/m2的单纯性肥胖患者分为观察组(EA联合按压针治疗)和对照组(单独EA治疗)。通过监测肥胖指标评估治疗效果。通过高脂饮食(HFD)建立肥胖大鼠模型,将大鼠随机分为肥胖对照组(未治疗)、EA组、EA联合按压针组。通过监测肥胖指标,使用染色技术检查脂肪和肝细胞形态,并通过qRT-PCR、western blot和免疫荧光分析评估肠淋巴管功能来评估治疗结果。结果:观察组患者体重(BW)、体重指数(BMI)、体脂率(F%)、腹围(A)、腰围(WC)及血清中VEGF-C、δ样配体4 (DLL4)、肾上腺髓质素(ADM)等肠淋巴功能相关因子水平均明显低于对照组。同样,与EA组相比,EA联合按压针可显著降低肥胖大鼠的肥胖指数、血清肠淋巴功能相关因子、改善淋巴管功能。机制上,EA联合按压针干预可抑制VEGF-C/VEGFR-3/PI3K/AKT信号通路。结论:电针联合按压针治疗单纯性肥胖的疗效明显优于单纯电针治疗。它通过调节VEGF-C/VEGFR-3/PI3K/AKT信号通路,改善淋巴管结构和功能,最终抑制肥胖来实现这一目标。
{"title":"Electroacupuncture Combined with Press Needles Alleviates Simple Obesity via VEGF-C/VEGFR-3/PI3K/AKT Signaling Pathway.","authors":"Bin Xu, Minghui Xia, Zhi Yu, Yuhang Wang, Donghua Liu, Yan Wang, Shuang Wu, Bin Xu","doi":"10.1159/000545330","DOIUrl":"10.1159/000545330","url":null,"abstract":"<p><p><p>Introduction: Simple obesity is an increasingly prevalent chronic condition. While electroacupuncture (EA) has demonstrated potential in addressing this issue, its effectiveness may be hindered by insufficient continuous stimulation and challenges related to patient adherence. This study aimed to compare the efficacy of EA alone versus EA combined with press needles in the treatment of simple obesity and to explore the underlying mechanisms contributing to weight loss.</p><p><strong>Methods: </strong>Eighty simple obese patients with a body mass index (BMI) ≥25.0 kg/m2 were divided into two groups: the observation group (treated with EA combined with press needles) and the control group (treated with EA alone). The efficacy of the treatments was evaluated by monitoring obesity indicators. Additionally, obesity rat models were established through a high-fat diet (HFD), and rats were randomly assigned to three groups: obesity control group (no treatment), EA group, and EA combined with press needles group. Treatment outcomes were assessed by monitoring obesity indicators, examining adipose and liver cell morphology using staining techniques, and evaluating intestinal lymphatic vessel function through qRT-PCR, Western blot, and immunofluorescence analyses.</p><p><strong>Results: </strong>The patients in the observation group exhibited significantly lower body weight (BW), BMI, body fat percentage (F%), abdominal circumference (A), waist circumference (WC), as well as serum levels of intestinal lymphatic function-related factors such as VEGF-C, delta-like ligand 4 (DLL4), and adrenomedullin (ADM) compared to the control group. Similarly, compared to EA group, EA combined with press needles significantly decreased obesity indexes, serum intestinal lymphatic function-related factors, and improved lymphatic vessel function in obese rats. Mechanistically, the VEGF-C/VEGFR-3/PI3K/AKT signaling pathway was inhibited by EA combined with press needles intervention.</p><p><strong>Conclusion: </strong>The combined therapy of EA with press needles had shown significantly superior efficacy in treating simple obesity compared to EA treatment alone. It achieved this by modulating the VEGF-C/VEGFR-3/PI3K/AKT signaling pathway, improving lymphatic vessel structure and function, and ultimately inhibiting obesity. </p>.</p>","PeriodicalId":19414,"journal":{"name":"Obesity Facts","volume":" ","pages":"348-363"},"PeriodicalIF":4.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12052376/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143664031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Food and Health Literacy in Patients Awaiting Metabolic-Bariatric Surgery. 等待代谢减重手术患者的饮食与健康知识。
IF 3.9 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-01 Epub Date: 2024-10-03 DOI: 10.1159/000541408
Anne Jacobs, Leontien M G Nijland, Ingrid H M Steenhuis, Ruben N van Veen, Ronald S L Liem, Hanno Pijl, Lies Ter Beek, Rob A E M Tollenaar, Valerie M Monpellier

Introduction: Specialized lifestyle programmes for patients undergoing metabolic-bariatric surgery (MBS) are provided to facilitate adjustment and adherence to a healthy lifestyle after surgery. However, pre-programme food and health literacy in MBS patients is often unknown. In the general population, approximately three-quarters of people exhibit sufficient health literacy. This study aimed to examine food and health literacy of patients awaiting MBS and to identify patient-specific factors associated with these literacies.

Methods: Patients awaiting MBS completed questionnaires on food literacy (Self-Perceived Food Literacy scale) and health literacy (European Health Literacy Survey Questionnaire-16) at the start of a preoperative lifestyle programme. Linear and logistic regression analyses were used to identify associations between multiple variables and preoperative food and health literacy.

Results: Among 216 patients, the preoperative mean food literacy score was 3.49 ± 0.44, on a five-point scale. Furthermore, 96.3% of patients showed sufficient health literacy, with scores of 13 or more out of 16. Patients with sufficient health literacy had higher food literacy scores (β 0.508; 95% CI: 0.208-0.809, p < 0.001).

Conclusion: This study among people living with obesity awaiting MBS suggests that food literacy is comparable, and health literacy is higher than in the general population. These findings emphasize the complexity of the aetiology of obesity due to factors that extend beyond food and health literacy.

导言:为接受代谢减肥手术(MBS)的患者提供专门的生活方式计划,以帮助他们在术后适应并坚持健康的生活方式。然而,代谢减重手术患者在手术前的饮食和健康知识往往不为人知。在普通人群中,大约四分之三的人具有足够的健康知识。本研究旨在调查等待接受乳房下垂矫正术的患者的食物和健康知识,并确定与这些知识相关的患者特定因素:方法:等待接受口腔手术的患者在术前生活方式计划开始时填写了关于食物知识(自我感觉食物知识量表)和健康知识(欧洲健康知识调查问卷-16)的问卷。采用线性和逻辑回归分析来确定多个变量与术前食物和健康素养之间的关系:结果:在 216 名患者中,术前食物知识平均得分为 3.49±0.44(5 分制)。此外,96.3%的患者表现出足够的健康素养,满分为 16 分,得分在 13 分或以上。具有足够健康素养的患者具有更高的食物素养得分(β 0.508; 95% CI: 0.208 - 0.809, p<.001):这项针对等待 MBS 的肥胖症患者的研究表明,与普通人群相比,他们的食物知识水平相当,而健康知识水平较高。这些发现强调了肥胖症病因的复杂性,其因素超出了食物和健康素养的范围。
{"title":"Food and Health Literacy in Patients Awaiting Metabolic-Bariatric Surgery.","authors":"Anne Jacobs, Leontien M G Nijland, Ingrid H M Steenhuis, Ruben N van Veen, Ronald S L Liem, Hanno Pijl, Lies Ter Beek, Rob A E M Tollenaar, Valerie M Monpellier","doi":"10.1159/000541408","DOIUrl":"10.1159/000541408","url":null,"abstract":"<p><strong>Introduction: </strong>Specialized lifestyle programmes for patients undergoing metabolic-bariatric surgery (MBS) are provided to facilitate adjustment and adherence to a healthy lifestyle after surgery. However, pre-programme food and health literacy in MBS patients is often unknown. In the general population, approximately three-quarters of people exhibit sufficient health literacy. This study aimed to examine food and health literacy of patients awaiting MBS and to identify patient-specific factors associated with these literacies.</p><p><strong>Methods: </strong>Patients awaiting MBS completed questionnaires on food literacy (Self-Perceived Food Literacy scale) and health literacy (European Health Literacy Survey Questionnaire-16) at the start of a preoperative lifestyle programme. Linear and logistic regression analyses were used to identify associations between multiple variables and preoperative food and health literacy.</p><p><strong>Results: </strong>Among 216 patients, the preoperative mean food literacy score was 3.49 ± 0.44, on a five-point scale. Furthermore, 96.3% of patients showed sufficient health literacy, with scores of 13 or more out of 16. Patients with sufficient health literacy had higher food literacy scores (β 0.508; 95% CI: 0.208-0.809, p < 0.001).</p><p><strong>Conclusion: </strong>This study among people living with obesity awaiting MBS suggests that food literacy is comparable, and health literacy is higher than in the general population. These findings emphasize the complexity of the aetiology of obesity due to factors that extend beyond food and health literacy.</p>","PeriodicalId":19414,"journal":{"name":"Obesity Facts","volume":" ","pages":"1-9"},"PeriodicalIF":3.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12017761/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142372442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Obesity Facts
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1